Journey Medical DERM Earnings Call Transcripts

NASDAQ DERM
$4.52 +0.05 (+1.12%)
At close: Nov 9, 2026 · 4:00 PM EST
2 earnings calls on file for Journey Medical, from Q1 2026 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Journey Medical Q2 2026 Earnings Call

Aug 12, 2026 5,813 words · 25 min read
  • Jaclyn JaffeSenior Director of Corporate Operations
  • Claude MaraouiCo-Founder, President and Chief Executive Officer
  • Joseph BeneschChief Financial Officer
  • Ramsey AlloushChief Operating Officer and General Counsel
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Journey Medical Earnings Call Transcripts

Calls2
LatestAug 12, 2026
SinceQ1 2026

Fiscal 2026

All 2 Journey Medical transcripts Register to get access to Journey Medical’s earnings call transcripts.